Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]

Xu, N., Chi, Z., Zhang, H., Wu, J., Sun, R., Tian, C. (2026). Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]. https://doi.org/10.1016/j.mtbio.2026.103024

Xu, Nannan, et al.. "Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]". CrossRef, 2026. doi:10.1016/j.mtbio.2026.103024.

@article{xu2026, author = {Nannan Xu and Zuofei Chi and He Zhang and Jiake Wu and Ruowen Sun and Chunyang Tian}, title = {Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]}, year = {2026}, journal = {CrossRef}, doi = {10.1016/j.mtbio.2026.103024}, url = {https://doi.org/10.1016/j.mtbio.2026.103024}, }

Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]

Penulis (6)

Format Sitasi

Akses Cepat